Sunshine Biopharma Inc. is a pharmaceutical company with two Canadian subsidiaries: Nora Pharma Inc., which markets 71 generic prescription drugs in Canada across oncology, cardiovascular, CNS, and other areas, and Sunshine Biopharma Canada Inc., which develops and sells OTC supplements. The company also conducts proprietary drug development including K1.1 mRNA (liver cancer) and SBFM-PL4 (SARS Coronavirus protease inhibitor), both in animal testing stages.
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-04-03 | 2025-12-31 | 0001683168-26-002644 | EDGAR | 35K words |
| 2025-04-01 | 2024-12-31 | 0001683168-25-002184 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0001683168-24-001818 | EDGAR | — |
| 2023-04-04 | 2022-12-31 | 0001683168-23-002128 | EDGAR | — |
| 2022-03-21 | 2021-12-31 | 0001683168-22-001788 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001654954-21-003507 | EDGAR | — |
| 2020-05-01 | 2019-12-31 | 0001654954-20-004731 | EDGAR | — |
| 2019-04-12 | 2018-12-31 | 0001654954-19-004354 | EDGAR | — |
| 2018-04-02 | 2017-12-31 | 0001654954-18-003495 | EDGAR | — |
| 2017-04-17 | 2016-12-31 | 0001654954-17-003365 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001683168-25-008328 | EDGAR | 13K words |
| 2025-08-12 | 2025-06-30 | 0001683168-25-005981 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001683168-25-003701 | EDGAR | — |
| 2024-11-05 | 2024-09-30 | 0001683168-24-007622 | EDGAR | — |
| 2024-08-16 | 2024-06-30 | 0001683168-24-005846 | EDGAR | — |
| 2024-05-20 | 2024-03-31 | 0001683168-24-003688 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001683168-23-007911 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001683168-23-005518 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001683168-23-003121 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0001683168-22-007290 | EDGAR | — |
| 2022-08-03 | 2022-06-30 | 0001683168-22-005298 | EDGAR | — |
| 2022-05-06 | 2022-03-31 | 0001683168-22-003262 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-09 | 0001683168-26-001609 | EDGAR | 3K words |
| 2026-02-20 | 0001683168-26-001216 | EDGAR | — |
| 2026-02-05 | 0001683168-26-000789 | EDGAR | — |
| 2025-12-12 | 0001683168-25-009103 | EDGAR | — |
| 2025-09-30 | 0001683168-25-007338 | EDGAR | — |
| 2025-05-19 | 0001683168-25-003838 | EDGAR | — |
| 2025-04-03 | 0001683168-25-002245 | EDGAR | — |
| 2025-04-02 | 0001683168-25-002193 | EDGAR | — |
| 2025-01-15 | 0001683168-25-000357 | EDGAR | — |
| 2024-12-10 | 0001683168-24-008607 | EDGAR | — |
183 total filings indexed. 151 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001402328 |
| Ticker | SBFM |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | CO |
| Website | https://www.sunshinebiopharma.com |
| Listed | 2007-08-09 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report